Marsh & McLennan Companies (NYSE:MRSH) Price Target Raised to $197.00

Posted by George Bondi on Oct 16th, 2026

Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) had its price target upped by investment analysts at Wells Fargo & Company from $183.00 to $197.00 in a research report issued on Friday, Benzinga reports. The brokerage presently has an “equal weight” rating on the financial services provider’s stock. Wells Fargo & Company‘s target price points to a potential upside of 5.15% from the stock’s current price.

MRSH has been the subject of a number of other reports. Morgan Stanley lowered their target price on Marsh & McLennan Companies from $200.00 to $180.00 and set an “equal weight” rating for the company in a research note on Tuesday, October 6th. JPMorgan Chase & Co. upped their price target on shares of Marsh & McLennan Companies from $212.00 to $215.00 and gave the company an “overweight” rating in a report on Thursday, October 1st. Bank of America lowered their price objective on shares of Marsh & McLennan Companies from $179.00 to $178.00 and set an “underperform” rating for the company in a research report on Wednesday, July 15th. Citigroup lowered shares of Marsh & McLennan Companies from a “buy” rating to a “neutral” rating and set a $200.00 price objective on the stock. in a report on Wednesday, July 22nd. Finally, Evercore dropped their price objective on shares of Marsh & McLennan Companies from $234.00 to $224.00 in a report on Thursday, October 8th. Two research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, twelve have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Marsh & McLennan Companies has an average rating of “Hold” and a consensus target price of $203.45.

Get Our Latest Stock Analysis on MRSH

Marsh & McLennan Companies Stock Performance

NYSE:MRSH traded up $0.81 on Friday, reaching $187.35. The company’s stock had a trading volume of 772,400 shares, compared to its average volume of 2,809,488. Marsh & McLennan Companies has a 1-year low of $156.60 and a 1-year high of $198.49. The stock’s 50-day moving average price is $181.22. The stock has a market cap of $89.41 billion, a price-to-earnings ratio of 22.86, a PEG ratio of 2.48 and a beta of 0.59. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 1.22.

Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last released its quarterly earnings results on Thursday, October 15th. The financial services provider reported $2.03 EPS for the quarter, topping analysts’ consensus estimates of $1.96 by $0.07. Marsh & McLennan Companies had a return on equity of 32.67% and a net margin of 14.24%. The company had revenue of $6.86 billion for the quarter. The firm’s quarterly revenue was up 8.1% compared to the same quarter last year. As a group, sell-side analysts expect that Marsh & McLennan Companies will post 10.43 EPS for the current year.

Insider Buying and Selling at Marsh & McLennan Companies

In other Marsh & McLennan Companies news, Director Lloyd Yates sold 12,000 shares of the business’s stock in a transaction that occurred on Thursday, July 23rd. The stock was sold at an average price of $175.65, for a total value of $2,107,800.00. Following the sale, the director owned 12,001 shares in the company, valued at approximately $2,107,975.65. The trade was a 50.00% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Martin South sold 7,100 shares of the company’s stock in a transaction that occurred on Tuesday, July 28th. The stock was sold at an average price of $189.99, for a total value of $1,348,929.00. Following the transaction, the insider directly owned 16,632 shares of the company’s stock, valued at approximately $3,159,913.68. This trade represents a 29.92% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 19,813 shares of company stock worth $3,597,903. Corporate insiders own 0.38% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the business. Continuum Advisory LLC lifted its holdings in Marsh & McLennan Companies by 5.3% in the 1st quarter. Continuum Advisory LLC now owns 1,452 shares of the financial services provider’s stock valued at $252,000 after purchasing an additional 73 shares in the last quarter. Clearstead Trust LLC boosted its stake in Marsh & McLennan Companies by 12.6% during the 1st quarter. Clearstead Trust LLC now owns 668 shares of the financial services provider’s stock worth $116,000 after purchasing an additional 75 shares during the last quarter. Columbia Bank grew its holdings in shares of Marsh & McLennan Companies by 5.1% during the first quarter. Columbia Bank now owns 1,736 shares of the financial services provider’s stock worth $301,000 after buying an additional 85 shares in the last quarter. Capital Analysts LLC raised its position in shares of Marsh & McLennan Companies by 37.4% in the second quarter. Capital Analysts LLC now owns 312 shares of the financial services provider’s stock valued at $52,000 after buying an additional 85 shares during the last quarter. Finally, KERR FINANCIAL PLANNING Corp raised its position in shares of Marsh & McLennan Companies by 26.8% in the second quarter. KERR FINANCIAL PLANNING Corp now owns 454 shares of the financial services provider’s stock valued at $76,000 after buying an additional 96 shares during the last quarter. Institutional investors and hedge funds own 87.99% of the company’s stock.

Key Marsh & McLennan Companies News

Here are the key news stories impacting Marsh & McLennan Companies this week:

Positive Sentiment: Q3 earnings and revenue beat estimates: Adjusted EPS was $2.03, above the $1.96 consensus estimate, while revenue reached $6.86 billion, up 8.1% year over year and approximately $220 million ahead of expectations. Marsh Reports Third Quarter 2026 Results
Positive Sentiment: Broad-based operating momentum: Growth in Consulting and Risk and Insurance Services helped drive results. Management reported 5% underlying revenue growth and double-digit EPS growth, supporting the view that demand for insurance, risk management and consulting remains resilient. Marsh Q3 Earnings Beat Estimates
Positive Sentiment: Strategic initiatives could support longer-term growth: The earnings call highlighted progress on the Thrive program, the completed brand transition and a greater focus on artificial intelligence. The company also unveiled a Resilience Coalition aimed at addressing rising global business risks, potentially strengthening its relevance with clients. Marsh & McLennan Earnings Call Highlights Growth and AI Focus
Neutral Sentiment: Analyst caution remains: RBC Capital maintained its Hold rating, suggesting the earnings strength and strategic progress may already be reflected in MRSH’s valuation. RBC Maintains Hold Rating
Negative Sentiment: Higher costs tempered the quarter: Rising operating expenses, including costs associated with ongoing transformation efforts, remain a risk to margins and could limit the benefit of revenue growth.

Marsh & McLennan Companies Company Profile

(Get Free Report)

Marsh & McLennan Companies, now operating under the name Marsh McLennan, is a global professional services firm that provides advice and solutions in risk, strategy and people. The company serves businesses, governments and institutions through four principal businesses: Marsh, Guy Carpenter, Mercer and Oliver Wyman.

Marsh is an insurance brokerage and risk adviser that helps clients identify, manage and transfer risk. Guy Carpenter provides reinsurance brokerage and advisory services to insurance companies.